Back
Fidelity Corporate Bond ETF Vs. Summit Therapeutics Industry Stock Comparison
Buy
61
FCOR
Fidelity Corporate Bond ETF
Last Price:
48.57
Seasonality Move:
-0.78%
Buy
79
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
Buy
61
Fidelity Corporate Bond ETF (FCOR)
is a Buy
Is Fidelity Corporate Bond ETF a Buy, Sell or Hold?
- The current Fidelity Corporate Bond ETF [FCOR] share price is $48.68. The Score for FCOR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- FCOR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $26.22. The Score for SMMT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FCOR Stock Price Chart
What is Fidelity Corporate Bond ETF's stock price today?
-
The Fidelity Corporate Bond ETF share price today is $48.68
The current trend is moderately bullish and FCOR is experiencing selling pressure, which indicates risk of future bearish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $26.22
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
FCOR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 72.31 | Buy |
| Chaikin Money Flow: | -30175 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.81 - 48.43) | Buy |
| Bollinger Bands (100): | (45.87 - 47.71) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.4 | Buy |
| Relative Strength Index (14 RSI): | 69.61 | Buy |
| Chaikin Money Flow: | -7453022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.89 - 22.53) | Buy |
| Bollinger Bands (100): | (4.23 - 14.99) | Buy |
FCOR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.5 | Buy |
| 20-day SMA: | 48.21 | Buy |
| 50-day SMA: | 47.53 | Buy |
| 200-day SMA: | 46.53 | Buy |
| 8-day EMA: | 48.5 | Buy |
| 20-day EMA: | 48.21 | Buy |
| 50-day EMA: | 47.65 | Buy |
| 200-day EMA: | 46.56 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.01 | Buy |
| 20-day SMA: | 17.36 | Buy |
| 50-day SMA: | 13.03 | Buy |
| 200-day SMA: | 6.61 | Buy |
| 8-day EMA: | 24.48 | Buy |
| 20-day EMA: | 19.28 | Buy |
| 50-day EMA: | 14.43 | Buy |
| 200-day EMA: | 8.04 | Buy |
Fidelity Corporate Bond ETF Earnings Growth & FCOR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Fidelity Corporate Bond ETF Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||